October 29, 2026StocksTechnology·Bullish·product
Hims & Hers rolls out Peptides+ specialty for compounded peptides following HHS policy
Hims & Hers is rolling out a new Peptides+ specialty for compounded peptides and related compounds, following the HHS enforcement discretion policy issued yesterday. The initial lineup includes Sermorelin, Glutathione, Vitamin B12, NAD+ and L-carnitine.
Detected & updated continuously · Source: Nebula
Story subjects